Success Metrics

Clinical Success Rate
87.1%

Based on 244 completed trials

Completion Rate
87%(244/280)
Active Trials
20(5%)
Results Posted
51%(125 trials)
Terminated
36(10%)

Phase Distribution

Ph phase_3
43
12%
Ph phase_4
67
18%
Ph phase_1
77
21%
Ph not_applicable
21
6%
Ph early_phase_1
15
4%
Ph phase_2
142
39%

Phase Distribution

92

Early Stage

142

Mid Stage

110

Late Stage

Phase Distribution365 total trials
Early Phase 1First-in-human
15(4.1%)
Phase 1Safety & dosage
77(21.1%)
Phase 2Efficacy & side effects
142(38.9%)
Phase 3Large-scale testing
43(11.8%)
Phase 4Post-market surveillance
67(18.4%)
N/ANon-phased studies
21(5.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

82.2%

244 of 297 finished

Non-Completion Rate

17.8%

53 ended early

Currently Active

20

trials recruiting

Total Trials

367

all time

Status Distribution
Active(24)
Completed(244)
Terminated(53)
Other(46)

Detailed Status

Completed244
unknown45
Terminated36
Withdrawn17
Recruiting14
Active, not recruiting6

Development Timeline

Analytics

Development Status

Total Trials
367
Active
20
Success Rate
87.1%
Most Advanced
Phase 4

Trials by Phase

Early Phase 115 (4.1%)
Phase 177 (21.1%)
Phase 2142 (38.9%)
Phase 343 (11.8%)
Phase 467 (18.4%)
N/A21 (5.8%)

Trials by Status

suspended10%
recruiting144%
active_not_recruiting62%
unknown4512%
withdrawn175%
enrolling_by_invitation21%
terminated3610%
completed24466%
not_yet_recruiting21%

Recent Activity

Clinical Trials (367)

Showing 20 of 367 trialsScroll for more
NCT03030248Phase 2

Vancomycin for C Difficile NAAT+/EIA- Hematology Oncology Patients

Completed
NCT03825536Phase 4

Effect of Methamphetamine on Residual Latent HIV Disease Study

Completed
NCT03850964Phase 2

Effects of Pazopanib on Hereditary Hemorrhagic Telangiectasia Related Epistaxis and Anemia (Paz)

Active Not Recruiting
NCT05350215Phase 1

Atomoxetine and DAW2022 on OSA Severity

Recruiting
NCT05288855Phase 3

Voclosporin in Adolescent and Pediatric Subjects With Lupus Nephritis

Terminated
NCT05207085Phase 2

Efficacy of Valbenazine for the Treatment of Trichotillomania in Adults

Recruiting
NCT03325322Phase 2

Inflammation and Stem Cells in Diabetic and Chronic Kidney Disease

Suspended
NCT07022353Not Applicable

Bi-level Erector Spinae Plane Block and Pre-emptive Oral Tizanidine for Analgesia After Mastectomy Surgery

Completed
NCT03667326Phase 2

Postpartum Low-Dose Aspirin and Preeclampsia

Recruiting
NCT05589792Phase 1

Acetazolamide on REM OSA

Completed
NCT06790537Phase 4

Efficacy of Pregabalin for Diabetic Pruritus - A Randomized Controlled Study.

Recruiting
NCT03420482Phase 2

Fecal Microbiota Transplant as Treatment of Hepatic Encephalopathy

Active Not Recruiting
NCT06617312Phase 2

Examining the Effects of Cytisinicline on Neural Substrates of Cigarette Cue-reactivity

Recruiting
NCT03675724Phase 2

Alleviation by Fisetin of Frailty, Inflammation, and Related Measures in Older Adults

Enrolling By Invitation
NCT04417257Phase 2

Study of LAU-7b for the Treatment of Coronavirus Disease 2019 (COVID-19) Disease in Adults

Terminated
NCT03430037Phase 2

Alleviation by Fisetin of Frailty, Inflammation, and Related Measures in Older Women

Enrolling By Invitation
NCT03845582Phase 2

Phase 2/3 Study of ALK-001 in Geographic Atrophy

Completed
NCT03455075Phase 2

Study of Spermatogenesis Suppression With DMAU Alone or With LNG Versus Placebo Alone in Normal Men

Completed
NCT03713424Phase 2

An fMRI Study of the Effects of Clavulanic Acid on Drug Addiction

Recruiting
NCT04014387Phase 4

Treatment of Disturbed Sleep in Progressive Supranuclear Palsy (PSP)

Completed

Drug Details

Intervention Type
DRUG
Total Trials
367